We re Not Counting On Inhalation Sciences Sweden (NGM:ISAB) To Sustain Its Statutory Profitability
By
December 29, 2020 Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability suggests a business is sustainable. That said, the current statutory profit is not always a good guide to a company s underlying profitability. In this article, we ll look at how useful this year s statutory profit is, when analysing
Inhalation Sciences Sweden (NGM:ISAB). It s good to see that over the last twelve months Inhalation Sciences Sweden made a profit of kr11.7m on revenue of kr12.1m. The chart below shows that revenue has improved over the last three years, and, even better, the company has moved from unprofitable to profitable.